Clinical Research Directory
Browse clinical research sites, groups, and studies.
Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)
Sponsor: Supernus Pharmaceuticals, Inc.
Summary
Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients
Official title: Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of SPN-812 for the Treatment of Pediatric Patients With Attention-Deficit/Hyperactivity Disorder (ADHD)
Key Details
Gender
All
Age Range
4 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
1400
Start Date
2016-02-02
Completion Date
2026-09
Last Updated
2025-06-25
Healthy Volunteers
No
Conditions
Interventions
SPN-812
Cohort 'A': Children 6-11 yrs of age take 100-400mg SPN-812 once daily by mouth and adolescents 12-17 yrs of age take 100-600mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'A' are given a choice to extend their participation in the study every 6 months for up to 72 months. Cohort 'B': Pre-school-age children 4-5 yrs of age take 100mg SPN-812 once daily by mouth. Pediatric subjects in Cohort 'B' will be treated with 100 mg SPN-812 (100 mg capsule) for up to 6 months.
Locations (16)
Woodland International Research Group
Little Rock, Arkansas, United States
Alliance for Wellness dba Alliance for Research
Long Beach, California, United States
MCB Clinical Research Centers, LLC
Colorado Springs, Colorado, United States
Meridien Research at Florida Clinical Research Center
Bradenton, Florida, United States
Sarkis Clinical Trials
Gainesville, Florida, United States
Indago Research & Health Center, Inc.
Hialeah, Florida, United States
Florida Clinical Research Center, LLC.
Maitland, Florida, United States
Florida Clinical Research Center, LLC
Maitland, Florida, United States
IPS Research
Oklahoma City, Oklahoma, United States
Paradigm Research Professionals
Oklahoma City, Oklahoma, United States
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
CNS Healthcare
Memphis, Tennessee, United States
Bayou City Research Corporation
Houston, Texas, United States
Road Runner Research
San Antonio, Texas, United States
Ericksen Research & Development
Clinton, Utah, United States
Northwest Clinical Trials
Bellevue, Washington, United States